Clinical Trials Browser

Completed × Neoplasm Metastasis × Ipilimumab × Clear all

NCT05665348 2026-03-09

TRIPLET

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT04326257 2026-01-08

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Phase 2 Completed

20 enrolled 13 charts

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT04021043 2025-12-03

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Phase 1/2 Completed

51 enrolled 16 charts

Neoplasm Metastasis

NCT03126110 2025-08-14

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Phase 1/2 Completed

145 enrolled 47 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Neoplasm Metastasis, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02259231 2025-06-04

RTA 408 Capsules in Patients With Melanoma - REVEAL

Phase 1/2 Completed

41 enrolled 15 charts

Melanoma, Neoplasm Metastasis

NCT03570619 2025-05-08

IMPACT

Phase 2 Completed

56 enrolled 18 charts

Neoplasm Metastasis

NCT02113657 2024-05-24

T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer

Phase EARLY_PHASE1 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT03126331 2024-03-18

Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT04084951 2023-04-14

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence

NCT03453892 2023-02-16

ST-ICI

Neoplasm Metastasis

NCT02115139 2022-11-08

GRAY-B

Phase 2 Completed

58 enrolled 15 charts

CNSDermatologic

Brain Neoplasms, Melanoma, Neoplasm Metastasis

NCT02977156 2022-07-25

ISI-JX

Phase 1 Completed

Neoplasm Metastasis

NCT02221739 2020-05-11

Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

39 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01363206 2020-03-19

GIPI

Phase 2 Completed

Melanoma, Neoplasm Metastasis

NCT00323882 2014-08-28

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase 1/2 Completed

75 enrolled 24 charts

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00094653 2011-07-11

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Phase 3 Completed

1,783 enrolled 29 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms